These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17366323)

  • 21. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
    DaCosta Byfield S; Major C; Laping NJ; Roberts AB
    Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5.
    Mallet C; Vittet D; Feige JJ; Bailly S
    Stem Cells; 2006 Nov; 24(11):2420-7. PubMed ID: 17071858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability.
    Birukova AA; Adyshev D; Gorshkov B; Birukov KG; Verin AD
    FEBS Lett; 2005 Jul; 579(18):4031-7. PubMed ID: 16004987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
    Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
    Mercado-Pimentel ME; Runyan RB
    Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
    Yoshizawa M; Miyazaki H; Kojima S
    J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.
    Dooley S; Delvoux B; Lahme B; Mangasser-Stephan K; Gressner AM
    Hepatology; 2000 May; 31(5):1094-106. PubMed ID: 10796885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model.
    Fu K; Corbley MJ; Sun L; Friedman JE; Shan F; Papadatos JL; Costa D; Lutterodt F; Sweigard H; Bowes S; Choi M; Boriack-Sjodin PA; Arduini RM; Sun D; Newman MN; Zhang X; Mead JN; Chuaqui CE; Cheung HK; Zhang X; Cornebise M; Carter MB; Josiah S; Singh J; Lee WC; Gill A; Ling LE
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):665-71. PubMed ID: 18202322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation.
    Castañares C; Redondo-Horcajo M; Magán-Marchal N; ten Dijke P; Lamas S; Rodríguez-Pascual F
    J Cell Sci; 2007 Apr; 120(Pt 7):1256-66. PubMed ID: 17376964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-specific expression of androgen and growth factor pathway genes in the rat epididymis and the effects of dual 5alpha-reductase inhibition.
    Henderson NA; Cooke GM; Robaire B
    J Endocrinol; 2006 Sep; 190(3):779-91. PubMed ID: 17003279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compensatory signalling induced in the yolk sac vasculature by deletion of TGFbeta receptors in mice.
    Carvalho RL; Itoh F; Goumans MJ; Lebrin F; Kato M; Takahashi S; Ema M; Itoh S; van Rooijen M; Bertolino P; Ten Dijke P; Mummery CL
    J Cell Sci; 2007 Dec; 120(Pt 24):4269-77. PubMed ID: 18029401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta inhibits vascular sprouting through TGF-beta type I receptor in the mouse embryonic aorta.
    Ito C; Akimoto T; Ioka T; Kobayashi T; Kusano E
    Tohoku J Exp Med; 2009 May; 218(1):63-71. PubMed ID: 19398875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-induced Physeal Abnormalities in Preclinical Toxicity Studies.
    Frazier KS
    Toxicol Pathol; 2017 Oct; 45(7):869-875. PubMed ID: 28643552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis.
    Petersen M; Thorikay M; Deckers M; van Dinther M; Grygielko ET; Gellibert F; de Gouville AC; Huet S; ten Dijke P; Laping NJ
    Kidney Int; 2008 Mar; 73(6):705-15. PubMed ID: 18075500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion.
    Dudas M; Kim J; Li WY; Nagy A; Larsson J; Karlsson S; Chai Y; Kaartinen V
    Dev Biol; 2006 Aug; 296(2):298-314. PubMed ID: 16806156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis.
    Andersson O; Reissmann E; Ibáñez CF
    EMBO Rep; 2006 Aug; 7(8):831-7. PubMed ID: 16845371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.